Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiparameter Prediction Model of Immune Checkpoint Inhibitors Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer: a Real-world Study

NCT05725915 is registered in ClinicalTrials.gov with Beijing Red Clove Public Welfare Development Center as lead sponsor.

NCT NCT05725915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05725915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiparameter Prediction Model of Immune Checkpoint Inhibitors Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer: a Real-world Study
Lead sponsor
Beijing Red Clove Public Welfare Development Center
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2022
Completion date
March 1, 2025
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, nonsmall cell